| Concentration | 9.0 - 11.0% w/w |
| Purity (HPLC) | |
| (±)-Cloprostenol | min. 97.5% rel. |
| 15S-(±)-cloprostenol | max. 0.5% rel. |
| 5,6-trans-(±)-cloprostenol | max. 2.0% rel. |
| Other impurities single | max. 0.1% rel. |
| Other impurities total | max. 0.5% rel. |
Product quality complies EP 2002 for category 2 and 3A of non-sterile products. Complete specification is available upon request.
© 2012 Cayman Pharma |